| Octapharma AG - Nuwiq 250 IE, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung |
| 65551 | | 01 | | Nuwiq 250 IE | | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | | B02BD02 | | Coagulation Factor Viii | | 26.05.2016 | | |
|
| Composition |
| Praeparatio cryodesiccata: simoctocogum alfa 250 U.I., saccharum, arginini hydrochloridum, poloxamerum 188, calcii chloridum dihydricum, natrii chloridum, natrii citras dihydricus pro vitro corresp. natrium 18.4 mg.
Solvens: aqua ad iniectabile 2.5 ml. |
| Packungsbestandteile |
| Praeparatio cryodesiccata: | | | Lyophilisate and solvent | | | | | | | | Active Agent | Dose |
|---|
| Simoctocogum Alfa | 250 UI |
| | BAG: Active Agent | Dose |
|---|
| Simoctocogum Alfa | 250 UI |
| | | | Inactive agents | Dose |
|---|
| Arginine Hydrochloride | | | Calcii Chloridum Dihydricum | | | Sodium Chloride | | | Natrii Citras Dihydricus | | | Poloxamer | 188 | | Saccharum | |
| |
|
| Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | Set(s) | 194.35 | 240.45 | B | SL | No |
|
